ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback